MK-0873

CAS No. 500355-52-2

MK-0873( —— )

Catalog No. M34654 CAS No. 500355-52-2

MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 222 Get Quote
5MG 333 Get Quote
10MG 504 Get Quote
25MG 790 Get Quote
50MG 1086 Get Quote
100MG 1431 Get Quote
500MG 2871 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    MK-0873
  • Note
    Research use only, not for human use.
  • Brief Description
    MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
  • Description
    MK-0873 is a novel and potent selective phosphodiesterase 4 (PDE4) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    PDE
  • Recptor
    PDE
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    500355-52-2
  • Formula Weight
    422.44
  • Molecular Formula
    C25H18N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(NC1CC1)(=O)C2=CN(C=3C(C2=O)=CC=CN3)C4=CC(C#CC5=CN(=O)=CC=C5)=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Triflusal

    Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.

  • MR-L2

    MR-L2 is a reversible and noncompetitive allosteric activator of long-isoform phosphodiesterase-4 (PDE4).

  • FCPR03

    FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively.